Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Shares Outstanding (Diluted Average) (2017 - 2021)

Pediatrix Medical (MD) has disclosed Shares Outstanding (Diluted Average) for 9 consecutive years, with $85.5 million as the latest value for Q1 2021.

  • Quarterly Shares Outstanding (Diluted Average) rose 3.25% to $85.5 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $85.5 million through Mar 2021, up 3.25% year-over-year, with the annual reading at $85.1 million for FY2020, 2.15% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2021 was $85.5 million at Pediatrix Medical, roughly flat from $85.1 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $93.5 million in Q2 2018, with the low at $82.8 million in Q1 2020.
  • Average Shares Outstanding (Diluted Average) over 5 years is $87.2 million, with a median of $85.3 million recorded in 2020.
  • The sharpest move saw Shares Outstanding (Diluted Average) dropped 10.52% in 2019, then grew 3.25% in 2021.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $93.0 million in 2017, then dropped by 1.45% to $91.6 million in 2018, then fell by 9.08% to $83.3 million in 2019, then rose by 2.15% to $85.1 million in 2020, then increased by 0.48% to $85.5 million in 2021.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $85.5 million, $85.1 million, and $83.9 million for Q1 2021, Q4 2020, and Q3 2020 respectively.